Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

WVE Wave Life Sciences Ltd

6,26

0,35 (5,92%)

Nach Börsenschluss

Zuletzt aktualisiert: 00:30:48

Verzögert um 15 Minuten

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Wave Life Sciences (NASDAQ:WVE)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Wave Life Sciences Charts.

Wave Life Sciences (NASDAQ:WVE)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Wave Life Sciences Charts.

News Wave Life Sciences Ltd

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Freitag 10 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 9 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Wave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update
Donnerstag 9 Mai 2024 (1 Woche vor) • GlobeNewswire Inc.

Wave Life Sciences Announces Appointment of Dr. Erik Ingelsson as Chief Scientific Officer
Donnerstag 9 Mai 2024 (1 Woche vor) • GlobeNewswire Inc.

Wave Life Sciences to Present at 2024 RBC Capital Markets Global Healthcare Conference
Dienstag 7 Mai 2024 (1 Woche vor) • GlobeNewswire Inc.

Wave Life Sciences First Quarter 2024 Financial Results Scheduled for May 9, 2024
Donnerstag 2 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency (AATD)
Dienstag 30 April 2024 (2 Wochen vor) • GlobeNewswire Inc.

Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing
Dienstag 23 April 2024 (3 Wochen vor) • GlobeNewswire Inc.

Wave Life Sciences to Present at Upcoming Investor Conferences
Mittwoch 27 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mittwoch 6 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 6 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Mittwoch 6 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Weitere Wave Life Sciences Ltd News-Artikel

Grupo Carso Sa de CV (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen